Publication | Open Access
Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma
68
Citations
40
References
2014
Year
The data suggest that inhibiting TLR7 and TLR9 with IRS-954 or chloroquine could potentially be used as a novel therapeutic approach for preventing HCC development and/or progression in susceptible patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1